Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

被引:32
|
作者
Schilder, C. M. T. [1 ]
Seynaeve, C. [2 ]
Linn, S. C. [3 ]
Boogerd, W. [4 ,5 ]
Beex, L. V. A. M. [6 ]
Gundy, C. M. [1 ]
Nortier, J. W. R. [7 ]
van de Velde, C. J. H. [8 ]
van Dam, F. S. A. M. [1 ]
Schagen, S. B. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, Erasmus Med Ctr, NL-3008 AE Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands
[5] Slotervaart Med Ctr, Dept Neurol, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[7] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands
关键词
Breast cancer; Postmenopausal; Cognitive function; Neuropsychological testing; Psychological function; Adjuvant systemic treatment; REPRODUCTIVE PERIOD; CHEMOTHERAPY; RISK; IMPAIRMENT; WOMEN; DYSFUNCTION; DEMENTIA; PEOPLE;
D O I
10.1016/j.critrevonc.2009.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to identify medical and psychological predictors for cognitive performance of breast cancer (BC) patients before the start of adjuvant systemic treatment and to compare cognitive performance between BC patients and healthy controls adjusting for medical and psychological variables. Material: 205 postmenopausal BC patients underwent pre-treatment neuropsychological tests and provided medical and psychological data. 124 healthy controls underwent the same assessment. Results: 'Treatment for diabetes mellitus' and/or 'hypertension', 'less hours spent on cognitively stimulating activities', 'fewer days since surgery' and 'more reproductive years' were associated with worse cognitive performance in the BC patients, independent of age and IQ. Cognitive differences between BC patients and healthy controls could partly be explained by the evaluated variables. Conclusion: The results stress the need for adjustment for pre-treatment cognitive differences between study groups, and also indicate that further research into pre-treatment cognitive dysfunction is warranted. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [1] Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy
    Biro, Edit
    Kahan, Zsuzsanna
    Kalman, Janos
    Rusz, Orsolya
    Pakaski, Magdolna
    Irinyi, Tamas
    Kelemen, Gyongyi
    Dudas, Rita
    Drotos, Gergely
    Hamvai, Csaba
    IN VIVO, 2019, 33 (04): : 1381 - 1392
  • [2] The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy
    Schilder, Christina M.
    Seynaeve, Caroline
    Linn, Sabine C.
    Boogerd, Willem
    Gundy, Chad M.
    Beex, Louk V.
    van Dam, Frits S.
    Schagen, Sanne B.
    PSYCHO-ONCOLOGY, 2010, 19 (04) : 415 - 422
  • [3] Cognitive Effects of Systemic Therapy in Patients with Breast Cancer
    Berndt, Ute
    Leplow, Bernd
    Kantelhardt, Eva
    Thomssen, Christoph
    BREAST CARE, 2009, 4 (03) : 177 - 182
  • [4] Role of stress, age and adjuvant therapy in the cognitive function of patients with breast cancer
    Papanastasiou, Artemis
    Seliniotaki, Theodora
    Rizos, Emmanouil
    Kampoli, Katerina
    Ntavatzikos, Anastasios
    Arkadopoulos, Nikolaos
    Tsionou, Christina
    Spandidos, Demetrios A.
    Koumarianou, Anna
    ONCOLOGY LETTERS, 2019, 18 (01) : 507 - 517
  • [5] Postmenopausal hormone therapy and its association with breast cancer
    Syal, Arshi
    Aggarwal, Neelam
    JOURNAL OF MID-LIFE HEALTH, 2020, 11 (04) : 187 - 195
  • [6] Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?
    Bender, Catherine M.
    Sereika, Susan M.
    Ryan, Christopher M.
    Brufsky, Adam M.
    Puhalla, Shannon
    Berga, Sarah L.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (09): : 922 - 929
  • [7] Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer Patients
    Gnant, Michael
    BREAST CARE, 2010, 5 (05) : 298 - 304
  • [8] Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer
    Vearncombe, Katharine Jean
    Pachana, Nancy A.
    AUSTRALIAN PSYCHOLOGIST, 2009, 44 (04) : 235 - 247
  • [9] Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy
    Chen, Vincent Chin-Hung
    Wu, Yi-Fang
    Tsai, Yuan-Hsiung
    Weng, Jun-Cheng
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [10] Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors
    Boscher, Clemence
    Joly, Florence
    Clarisse, Benedicte
    Humbert, Xavier
    Grellard, Jean-Michel
    Binarelli, Giulia
    Tron, Laure
    Licaj, Idlir
    Lange, Marie
    CANCERS, 2020, 12 (10) : 1 - 13